Patients suspecting they have multiple sclerosis (MS) are encountering significant delays in accessing specialist care, with ...

Multiple sclerosis, which affects around one in 500 people in Switzerland, is an autoimmune disease in which immune cells ...

—Data from this real-world study revealed that patients with MS being treated with DMTs had a disproportionally higher number of cases of herpes zoster compared with patients treated with other ...

Discover the groundbreaking medical trial offering new hope for autoimmune diseases and the first courageous patient behind its success.

People with MS are more than twice as likely to experience headaches, including migraines, than their healthy counterparts, ...

Research presented recently at the ECTRIMS Congress 2025 highlights the patient perspective on menopause and MS.

Sepsis is an alarmingly common cause behind ICU admissions in patients with multiple sclerosis (MS), a retrospective, population-based cohort study indicates. Furthermore, it contributes to a ...

Andrew Wolf, MD, discusses the growing costs, treatment advances, and geographic disparities in multiple sclerosis care.

Patients suspecting they have multiple sclerosis (MS) are encountering significant delays in accessing specialist care, with ...

Patients with MS (114 [87.7%] with RRMS; 16 [12.3%] with SPMS) who discontinued first-line DMT were included in the analysis. Over a median follow-up of 59.5 months, 78 patients who discontinued DMT ...

Sleep disorders are highly prevalent among individuals with multiple sclerosis (MS), affecting nearly half of the patient population, according to study results presented at the European Committee for ...